US Stock MarketDetailed Quotes

Apyx Medical (APYX)

Watchlist
  • 3.720
  • -0.080-2.11%
Close Apr 24 15:59 ET
  • 3.720
  • 0.0000.00%
Post 20:01 ET
155.60MMarket Cap-13.78P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apyx Medical (APYX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
55.67%-8M
13.86%-2.53M
20.36%-3.54M
71.52%-1.23M
88.93%-702K
-243.82%-18.05M
-32.78%-2.94M
-220.13%-4.44M
10.78%-4.33M
-237.11%-6.34M
Net income from continuing operations
52.86%-11.11M
73.38%-1.24M
58.62%-1.96M
43.24%-3.74M
45.03%-4.17M
-24.98%-23.56M
51.59%-4.66M
-1.05%-4.72M
-546.32%-6.59M
-114.89%-7.59M
Operating gains losses
46.15%19K
--0
----
----
----
-97.67%13K
-101.09%-35K
-22.22%28K
--0
--20K
Depreciation and amortization
9.35%655K
55.63%221K
13.89%164K
-15.38%132K
-12.10%138K
-13.44%599K
-6.58%142K
-22.58%144K
3.31%156K
-22.66%157K
Other non cash items
-17.89%1.04M
-49.51%260K
5.22%262K
2.77%260K
3.17%260K
100.79%1.27M
131.98%515K
39.11%249K
54.27%253K
276.12%252K
Change In working capital
-27.79%-1.59M
-600.00%-2.76M
-119.98%-2.72M
84.71%1.29M
923.17%2.59M
-122.46%-1.25M
-117.49%-394K
-119.17%-1.24M
121.13%700K
-301.92%-315K
-Change in receivables
35.23%-1.32M
-33.67%-3.9M
-496.10%-1.84M
261.86%471K
166.71%3.94M
-151.25%-2.04M
-110.85%-2.91M
-104.40%-308K
87.23%-291K
134.60%1.48M
-Change in inventory
-147.46%-1.07M
-62.45%511K
-343.66%-865K
-227.38%-521K
-244.20%-199K
55.11%2.26M
28.64%1.36M
366.92%355K
218.55%409K
-84.30%138K
-Change in prepaid assets
-72.35%237K
-27.62%228K
-242.74%-425K
-6.59%397K
-84.65%37K
555.85%857K
-38.24%315K
80.66%-124K
146.45%425K
-71.91%241K
-Change in payables and accrued expense
124.21%564K
-52.84%398K
135.12%407K
502.55%946K
45.35%-1.19M
-874.09%-2.33M
-59.17%844K
-626.82%-1.16M
-30.22%157K
1.76%-2.17M
Cash from discontinued investing activities
Operating cash flow
55.67%-8M
13.86%-2.53M
20.36%-3.54M
71.52%-1.23M
88.93%-702K
-243.82%-18.05M
-32.78%-2.94M
-220.13%-4.44M
10.78%-4.33M
-237.11%-6.34M
Investing cash flow
Cash flow from continuing investing activities
-54.29%-1.11M
-12.24%-275K
-239.22%-519K
8.30%-265K
-57.14%-55K
-110.72%-722K
-163.44%-245K
12.07%-153K
-104.06%-289K
68.18%-35K
Net PPE purchase and sale
-54.29%-1.11M
-12.24%-275K
-239.22%-519K
8.30%-265K
-57.14%-55K
-110.72%-722K
-163.44%-245K
12.07%-153K
-104.06%-289K
68.18%-35K
Cash from discontinued investing activities
Investing cash flow
-54.29%-1.11M
-12.24%-275K
-239.22%-519K
8.30%-265K
-57.14%-55K
-110.72%-722K
-163.44%-245K
12.07%-153K
-104.06%-289K
68.18%-35K
Financing cash flow
Cash flow from continuing financing activities
42.03%9.58M
40.31%9.49M
1,000.00%45K
600.00%25K
600.00%25K
-79.03%6.75M
-71.65%6.76M
-103.05%-5K
-110.87%-5K
-100.06%-5K
Net issuance payments of debt
0.00%-20K
-20.00%-6K
20.00%-4K
0.00%-5K
0.00%-5K
-100.06%-20K
-100.02%-5K
99.17%-5K
50.00%-5K
-100.05%-5K
Net common stock issuance
32.86%9.3M
----
----
----
----
--7M
----
----
----
----
Proceeds from stock option exercised by employees
--488K
--439K
----
----
----
--0
--0
--0
----
----
Net other financing activities
20.00%-188K
---248K
--0
--30K
--30K
92.06%-235K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
42.03%9.58M
40.31%9.49M
1,000.00%45K
600.00%25K
600.00%25K
-79.03%6.75M
-71.65%6.76M
-103.05%-5K
-110.87%-5K
-100.06%-5K
Net cash flow
Beginning cash position
-27.29%31.74M
-10.27%25.14M
-10.33%29.3M
-16.82%31.01M
-27.29%31.74M
328.30%43.65M
26.56%28.01M
76.84%32.68M
129.36%37.28M
328.30%43.65M
Current changes in cash
103.87%465K
86.70%6.68M
12.79%-4.01M
68.14%-1.47M
88.53%-732K
-135.73%-12.02M
-83.39%3.58M
-224.74%-4.6M
-300.56%-4.62M
-204.25%-6.38M
Effect of exchange rate changes
-512.39%-466K
-150.00%-75K
-132.84%-156K
-1,347.37%-237K
-81.82%2K
159.16%113K
814.29%150K
-116.13%-67K
123.46%19K
118.97%11K
End cash Position
-0.00%31.74M
-0.00%31.74M
-10.27%25.14M
-10.33%29.3M
-16.82%31.01M
-27.29%31.74M
-27.29%31.74M
26.56%28.01M
76.84%32.68M
129.36%37.28M
Free cash flow
51.44%-9.12M
11.85%-2.81M
11.71%-4.06M
67.56%-1.5M
88.13%-757K
-224.61%-18.77M
-38.05%-3.18M
-230.41%-4.59M
7.79%-4.62M
-220.24%-6.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 55.67%-8M13.86%-2.53M20.36%-3.54M71.52%-1.23M88.93%-702K-243.82%-18.05M-32.78%-2.94M-220.13%-4.44M10.78%-4.33M-237.11%-6.34M
Net income from continuing operations 52.86%-11.11M73.38%-1.24M58.62%-1.96M43.24%-3.74M45.03%-4.17M-24.98%-23.56M51.59%-4.66M-1.05%-4.72M-546.32%-6.59M-114.89%-7.59M
Operating gains losses 46.15%19K--0-------------97.67%13K-101.09%-35K-22.22%28K--0--20K
Depreciation and amortization 9.35%655K55.63%221K13.89%164K-15.38%132K-12.10%138K-13.44%599K-6.58%142K-22.58%144K3.31%156K-22.66%157K
Other non cash items -17.89%1.04M-49.51%260K5.22%262K2.77%260K3.17%260K100.79%1.27M131.98%515K39.11%249K54.27%253K276.12%252K
Change In working capital -27.79%-1.59M-600.00%-2.76M-119.98%-2.72M84.71%1.29M923.17%2.59M-122.46%-1.25M-117.49%-394K-119.17%-1.24M121.13%700K-301.92%-315K
-Change in receivables 35.23%-1.32M-33.67%-3.9M-496.10%-1.84M261.86%471K166.71%3.94M-151.25%-2.04M-110.85%-2.91M-104.40%-308K87.23%-291K134.60%1.48M
-Change in inventory -147.46%-1.07M-62.45%511K-343.66%-865K-227.38%-521K-244.20%-199K55.11%2.26M28.64%1.36M366.92%355K218.55%409K-84.30%138K
-Change in prepaid assets -72.35%237K-27.62%228K-242.74%-425K-6.59%397K-84.65%37K555.85%857K-38.24%315K80.66%-124K146.45%425K-71.91%241K
-Change in payables and accrued expense 124.21%564K-52.84%398K135.12%407K502.55%946K45.35%-1.19M-874.09%-2.33M-59.17%844K-626.82%-1.16M-30.22%157K1.76%-2.17M
Cash from discontinued investing activities
Operating cash flow 55.67%-8M13.86%-2.53M20.36%-3.54M71.52%-1.23M88.93%-702K-243.82%-18.05M-32.78%-2.94M-220.13%-4.44M10.78%-4.33M-237.11%-6.34M
Investing cash flow
Cash flow from continuing investing activities -54.29%-1.11M-12.24%-275K-239.22%-519K8.30%-265K-57.14%-55K-110.72%-722K-163.44%-245K12.07%-153K-104.06%-289K68.18%-35K
Net PPE purchase and sale -54.29%-1.11M-12.24%-275K-239.22%-519K8.30%-265K-57.14%-55K-110.72%-722K-163.44%-245K12.07%-153K-104.06%-289K68.18%-35K
Cash from discontinued investing activities
Investing cash flow -54.29%-1.11M-12.24%-275K-239.22%-519K8.30%-265K-57.14%-55K-110.72%-722K-163.44%-245K12.07%-153K-104.06%-289K68.18%-35K
Financing cash flow
Cash flow from continuing financing activities 42.03%9.58M40.31%9.49M1,000.00%45K600.00%25K600.00%25K-79.03%6.75M-71.65%6.76M-103.05%-5K-110.87%-5K-100.06%-5K
Net issuance payments of debt 0.00%-20K-20.00%-6K20.00%-4K0.00%-5K0.00%-5K-100.06%-20K-100.02%-5K99.17%-5K50.00%-5K-100.05%-5K
Net common stock issuance 32.86%9.3M------------------7M----------------
Proceeds from stock option exercised by employees --488K--439K--------------0--0--0--------
Net other financing activities 20.00%-188K---248K--0--30K--30K92.06%-235K----------------
Cash from discontinued financing activities
Financing cash flow 42.03%9.58M40.31%9.49M1,000.00%45K600.00%25K600.00%25K-79.03%6.75M-71.65%6.76M-103.05%-5K-110.87%-5K-100.06%-5K
Net cash flow
Beginning cash position -27.29%31.74M-10.27%25.14M-10.33%29.3M-16.82%31.01M-27.29%31.74M328.30%43.65M26.56%28.01M76.84%32.68M129.36%37.28M328.30%43.65M
Current changes in cash 103.87%465K86.70%6.68M12.79%-4.01M68.14%-1.47M88.53%-732K-135.73%-12.02M-83.39%3.58M-224.74%-4.6M-300.56%-4.62M-204.25%-6.38M
Effect of exchange rate changes -512.39%-466K-150.00%-75K-132.84%-156K-1,347.37%-237K-81.82%2K159.16%113K814.29%150K-116.13%-67K123.46%19K118.97%11K
End cash Position -0.00%31.74M-0.00%31.74M-10.27%25.14M-10.33%29.3M-16.82%31.01M-27.29%31.74M-27.29%31.74M26.56%28.01M76.84%32.68M129.36%37.28M
Free cash flow 51.44%-9.12M11.85%-2.81M11.71%-4.06M67.56%-1.5M88.13%-757K-224.61%-18.77M-38.05%-3.18M-230.41%-4.59M7.79%-4.62M-220.24%-6.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -